Clinical Trials in France / NCT04932525
Recruiting
Not applicable
Gustave Roussy Cancer Profiling
NCT04932525 · tracked via the Priya Life Science France tracker
Condition(s) studied
Solid Tumor, Unspecified, Adult
Investigational drug(s) / intervention(s)
Biopsy
Biopsy: Blood and tumor samples for Genetic Profiling research
Study summary
The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.
Eligibility
Inclusion Criteria:
1. Age ≥ 18 years
2. Histology: solid malignant tumor or hematological malignancy.
3. Patient with a social security in compliance with the French law relating to biomedical research (Article L.1121-11 of French Public Health Code)
4. Voluntary signed and dated written informed consent prior to any study specific procedure.
Exclusion Criteria:
1. Any condition which in the Investigator's opinion makes it undesirable for the subject to participate in a clinical trial or which would jeopardize compliance with the protocol
2. Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent
3. Pregnant or breast-feeding women
4. Minors (Age \< 18 years)
Primary outcome measure(s)
- Number of patients presenting at least one targetable genomic alteration — 2 months after the last enrollment
Number of patients presenting at least one targetable genomic alteration - Proportion of patients presenting at least one targetable genomic alteration — 2 months after the last enrollment
Proportion of patients presenting at least one targetable genomic alteration
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Gustave Roussy Cancer Campus Grand Paris | Villejuif | Val de Marne | Recruiting |
| Hôpital Marie-Lannelongue | Le Plessis-Robinson | France | Recruiting |
| Hôpital Saint-Joseph | Paris | France | Not Yet Recruiting |
| Hôpital Foch | Suresnes | France | Not Yet Recruiting |
More Gustave Roussy, Cancer Campus, Grand Paris trials in France
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04932525 on ClinicalTrials.gov ↗ ← All trials in France